Artwork

Contenuto fornito da Saul Marquez. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Saul Marquez o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !

Unlocking New Frontiers in Alzheimer’s Treatment with Christian Howell, CEO of Cognito Therapeutics

19:53
 
Condividi
 

Manage episode 454777717 series 2893730
Contenuto fornito da Saul Marquez. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Saul Marquez o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

Non-invasive neurostimulation technology can significantly slow cognitive and functional decline in Alzheimer's patients by stimulating brain activity with a new approach.

In this episode, Christian Howell, CEO of Cognito Therapeutics, highlights the limited progress in Alzheimer's disease modification, noting recent monoclonal antibodies targeting amyloid plaque but with concerns about efficacy and cost. He also discusses Cognito's groundbreaking work on Alzheimer's treatments and explains how their innovative device, Spectris, offers a promising non-invasive therapy. Christian explains how Cognito is actively gathering evidence for Spectris' approval and market launch, envisioning its application for various neurodegenerative conditions, broader aging-related cognitive decline, and metabolic health, showcasing the potential of neurostimulation in driving biological brain changes.

Tune in to discover the future of non-invasive neurostimulation and the benefits this new technology could bring to Alzheimer's patients!

Resources:

  • Connect with and follow Christian Howell on LinkedIn.
  • Follow Cognito Therapeutics on LinkedIn and explore their Website.
  • Find the Nature paper about Spectris here.
  continue reading

1861 episodi

Artwork
iconCondividi
 
Manage episode 454777717 series 2893730
Contenuto fornito da Saul Marquez. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Saul Marquez o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

Non-invasive neurostimulation technology can significantly slow cognitive and functional decline in Alzheimer's patients by stimulating brain activity with a new approach.

In this episode, Christian Howell, CEO of Cognito Therapeutics, highlights the limited progress in Alzheimer's disease modification, noting recent monoclonal antibodies targeting amyloid plaque but with concerns about efficacy and cost. He also discusses Cognito's groundbreaking work on Alzheimer's treatments and explains how their innovative device, Spectris, offers a promising non-invasive therapy. Christian explains how Cognito is actively gathering evidence for Spectris' approval and market launch, envisioning its application for various neurodegenerative conditions, broader aging-related cognitive decline, and metabolic health, showcasing the potential of neurostimulation in driving biological brain changes.

Tune in to discover the future of non-invasive neurostimulation and the benefits this new technology could bring to Alzheimer's patients!

Resources:

  • Connect with and follow Christian Howell on LinkedIn.
  • Follow Cognito Therapeutics on LinkedIn and explore their Website.
  • Find the Nature paper about Spectris here.
  continue reading

1861 episodi

Tutti gli episodi

×
 
Loading …

Benvenuto su Player FM!

Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.

 

Guida rapida